Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
Wednesday, January 29, 2025Genialis the RNA biomarker company today announced an extension of its collaboration with Debiopharm a Swissbased global biopharmaceutical company to develop a predictive biomarker for WEEtargeted therapy This extension builds on a agreement to defi...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Tuesday, January 28, 2025Alvotecha global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd today announced that the US Food and Drug Ad...
ONCOMATRYX Raises €25 Million to Foster OMTX705 Clinical Trials
Tuesday, January 28, 2025ONCOMATRYX a biopharmaceutical company developing novel ADCs against the tumor microenvironment has successfully raised million to fund Phase IbII clinical trials of OMTX a firstinclass ADC targeting FAP
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Monday, January 27, 2025Eisai Co Ltdand Biogen Inc Nasdaq BIIB Corporate headquarters Cambridge Massachusetts CEO Christopher A Viehbacher Biogen announced today that the US Food and Drug Administration FDA has approved the Supplemental Biologics License Application sBLA fo...
AbbVie Completes Acquisition of Nimble Therapeutics
Friday, January 24, 2025AbbVie announced today that it has completed its acquisition of Nimble Therapeutics With the completion of the acquisition Nimble is now a part of AbbVie
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
Friday, January 24, 2025Cancer Research UK Cytovation and the Norwegian Cancer Society have signed an agreement to bring Cytovations lead asset CY into a multinational Phase clinical trial for patients with adrenocortical carcinoma ACC
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
Thursday, January 23, 2025RELIEF THERAPEUTICS Holding SA a biopharmaceutical company committed to delivering innovative treatment options for select specialty unmet and rare diseases today announced the sale of its intellectual property and commercialization rights for GOLIKE...
Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizons Capital to Advance SJP-001 Clinical Trial with Novotech
Thursday, January 23, 2025SenJam Pharmaceutical a leader in innovative solutions targeting inflammation and metabolic health proudly announces a financial and strategic investment from Horizons Capital Horizon as the lead investor for the Phase clinical trial of SJP SenJams...
Extended Collaboration with Sartorius Powers New Biomanufacturing Lab at McMaster University, Canada
Wednesday, January 22, 2025The life science group Sartorius and McMaster University today opened a new bioprocessing automation lab at the universitys Faculty of Engineering in Hamilton Ontario The stateoftheart squarefoot research facility
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Earns FDA Clearance to Continue Remote Ingestion, Further Expanding Access and Comfort for Patients
Wednesday, January 22, 2025CapsoVision Inc a leader in innovative endoscopic capsule technology today announced that its awardwinning product the CapsoCam Plus capsule endoscopy system has received US Food Drug Administration FDA clearance
